Ardevora Asset Management LLP Biogen Inc. Transaction History

Ardevora Asset Management LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 14, 2021	SELL	$236.26 - $355.63 $37.5 Million - $56.4 Million	-158,531 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$264.77 - $305.71 $3.02 Million - $3.49 Million	11,400 Added 7.75%	158,531 $45 Million
Q2 2020 Jul 28, 2020	BUY	$258.66 - $342.55 $4.95 Million - $6.55 Million	19,131 Added 14.95%	147,131 $39.4 Million
Q1 2020 Apr 28, 2020	BUY	$268.85 - $341.04 $34.4 Million - $43.7 Million	128,000 New	128,000 $40.5 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Ardevora Asset Management LLP with notifications on news.